Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
173307016 | Goserelin acetate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
604531016 | Goserelin acetate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
815201000172114 | acétate de goséréline | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
815211000172112 | goserelineacetaat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Goserelin acetate preparation | Has active ingredient | False | Goserelin acetate | Inferred relationship | Some | |
Goserelin acetate 3.6mg implant | Has active ingredient | False | Goserelin acetate | Inferred relationship | Some | |
Goserelin acetate 10.8mg implant prefilled syringe | Has active ingredient | False | Goserelin acetate | Inferred relationship | Some | |
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has precise active ingredient | True | Goserelin acetate | Inferred relationship | Some | 1 |
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has precise active ingredient | True | Goserelin acetate | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug